Does Lp-PLA2 hydrolyze oxidized LDL to generate pro-inflammatory lipids that drive plaque vulnerability?

Lipoprotein-associated phospholipase A2 (Lp-PLA2) serves as a critical bridge between lipid oxidation and vascular inflammation. Research confirms that this enzyme is an active participant in the progression of atherosclerosis, rather than just a passive marker of disease.

Mechanistic role and enzymatic action

The biological function of Lp-PLA2 is centered on its specific interaction with oxidized low-density lipoprotein (oxLDL).

• Production in plaques: Lp-PLA2 is primarily synthesized and secreted by inflammatory cells—specifically macrophages and lipid-laden foam cells—within the atherosclerotic plaque itself. Levels of the enzyme are significantly higher in advanced, symptomatic lesions compared to stable plaques.
• Enzymatic hydrolysis: Once localized to the plaque, the enzyme targets oxidatively modified phospholipids. Specifically, it cleaves the ester bond at the sn-2 position of oxidized phosphatidylcholines on the surface of LDL particles.
• Generation of bioactive products: This cleavage consistently produces two potent pro-inflammatory mediators: lysophosphatidylcholine (LPC) and oxidized non-esterified fatty acids (Ox-NEFA). While this process was historically viewed as a way to remove oxidized lipids, it is now understood that the products of this reaction are significantly more bioactive and damaging than the parent molecules.

Impact on endothelial health and plaque stability

The products generated by Lp-PLA2 activity directly drive the pathology of the vascular wall.

• Endothelial inflammation: LPC acts as a powerful signaling molecule that activates pathways including NF-κB and NADPH oxidase. This leads to increased production of reactive oxygen species (ROS), cytokines like IL-8, and adhesion molecules that recruit more leukocytes to the arterial wall.
• Plaque vulnerability: Chronic exposure to these hydrolysis products impairs endothelial repair and facilitates the formation of a thin, fragile fibrous cap. By promoting apoptosis in macrophages and smooth muscle cells, Lp-PLA2 activity contributes to the development of a large necrotic core, a hallmark of plaques at high risk for rupture.

Bottom line

Lp-PLA2 is a macrophage-derived enzyme that hydrolyzes oxidized LDL into lysophosphatidylcholine and oxidized fatty acids. These products are direct drivers of endothelial dysfunction and plaque instability, making Lp-PLA2 a central mechanism in the transition from stable to high-risk atherosclerotic disease.